These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 145893)

  • 1. Platelet dopamine uptake in Huntington's chorea and Gilles de la Tourette's syndrome: effect of haloperidol.
    Butterworth RF; Gonce M; Barbeau A
    Can J Neurol Sci; 1977 Nov; 4(4):285-8. PubMed ID: 145893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamine metabolism in Gilles de la Tourette's syndrome.
    Lake CR; Ziegler MG; Eldridge R; Murphy DL
    Am J Psychiatry; 1977 Mar; 134(3):257-60. PubMed ID: 265141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Simon effect and attention deficits in Gilles de la Tourette's syndrome and Huntington's disease.
    Georgiou N; Bradshaw JL; Phillips JG; Bradshaw JA; Chiu E
    Brain; 1995 Oct; 118 ( Pt 5)():1305-18. PubMed ID: 7496788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of endogenous dopamine metabolism in Gilles de la Tourette's disease.
    Messiha FS; Knopp W
    Dis Nerv Syst; 1976 Aug; 37(8):470-3. PubMed ID: 1066216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gilles de la Tourette's syndrome: biochemical approaches.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():459-65. PubMed ID: 1070064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of dopamine antagonists in spontaneous and tardive dyskinesia.
    Fog R
    Psychopharmacology Suppl; 1985; 2():118-21. PubMed ID: 2860655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers for Huntington's chorea.
    McLean DR; Nihei T
    Can J Neurol Sci; 1980 Nov; 7(4):281-3. PubMed ID: 6260324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic function in Gilles de la Tourette's syndrome, Sydenham's chorea and torsion dystonia.
    Lal S; Allen J; Etienne P; Sourkes TL; Humphreys P
    Clin Neurol Neurosurg; 1976; 79(1):66-9. PubMed ID: 1070416
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased dopamine uptake into platelet storage granules in Gilles de la Tourette disease.
    Rabey JM; Oberman Z; Graff E; Korczyn AD
    Biol Psychiatry; 1995 Jul; 38(2):112-5. PubMed ID: 7578642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine uptake capacity of platelets from people at risk for Huntington's chorea.
    McLean DR; Nihei T
    Can J Neurol Sci; 1981 May; 8(2):167-8. PubMed ID: 6457680
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet monoamine uptake in relatives of patients with Huntington's chorea.
    Ehsanullah RS; Turner P
    Postgrad Med J; 1981 Aug; 57(670):479-81. PubMed ID: 6458032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of dopamine and 5-hydroxytryptamine by platelets from patients with Huntington's chorea.
    McLean DR; Nihei T
    Lancet; 1977 Jan; 1(8005):249-50. PubMed ID: 64769
    [No Abstract]   [Full Text] [Related]  

  • 13. Familial incidence of Gilles de la Tourette's disease, with observations on aetiology and treatment.
    Friel PB
    Br J Psychiatry; 1973 Jun; 122(571):655-8. PubMed ID: 4146056
    [No Abstract]   [Full Text] [Related]  

  • 14. Uptake of 14C-dopamine in platelets of Huntington's chorea patients and symptom-free offspring.
    Bonilla E; Vargas-Urribari N; Navas F
    Lancet; 1978 Jul; 2(8081):161-2. PubMed ID: 78368
    [No Abstract]   [Full Text] [Related]  

  • 15. Uptake of 5-hydroxytryptamine by blood platelets in Huntington's chorea and Alzheimer type of presenile dementia.
    Tukiainen E; Wikström J; Kilpeläinen H
    Med Biol; 1981 Apr; 59(2):116-20. PubMed ID: 6458746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF cholinesterase activity in Gilles de la Tourette's syndrome.
    Singer HS; Oshida L; Coyle JT
    Arch Neurol; 1984 Jul; 41(7):756-7. PubMed ID: 6588929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Accessory symptomatology and therapy of Gilles de la Tourette's disease].
    Achkova M; Terziev D
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(10):1516-8. PubMed ID: 3480667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gilles de la Tourette's syndrome following methylphenidate administration.
    Golden GS
    Dev Med Child Neurol; 1974 Feb; 16(1):76-8. PubMed ID: 4521612
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome.
    Ross MS; Moldofsky H
    Am J Psychiatry; 1978 May; 135(5):585-7. PubMed ID: 347954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of familial exhibitionism in Tourette's syndrome successfully treated with haloperidol.
    Comings DE; Comings BG
    Am J Psychiatry; 1982 Jul; 139(7):913-5. PubMed ID: 6953768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.